Minimal Fallout for Life Science Firms from Japanese Quake, Analyst Says

In a research note, Jon Groberg wrote that in the near term firms with a larger consumables presence in Japan face greater revenue risk, while instrument firms face greater mid-term risk.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.